← Leaderboards
Akshay Nitin Gupte
Johns Hopkins University
$2,395,374
Attributed
$4,031,349
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,031,349 · 4
By mechanism
R01$3,271,951 · 2
R00$488,666 · 1
K99$270,732 · 1
Top collaborators
- Jonathan E Golub5 shared
- Devasahayam Jesudas Christopher4 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Irina Petrache$14,015,590
- Eric Christian Donny$23,667,527
- Jonathan E Golub$18,054,199
- James M Tielsch$17,428,062
- Enid R Neptune$11,248,461
Others in their field
Other Emerging Leaders on “Lung Diseases”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$49,374,001
- Prasant Mohapatra · University Of California At Davis$40,346,250
- Lynn Briscoe · Leidos Biomedical Research, Inc.$23,229,499
- Ashlin Bolton · Broad Institute, Inc.$22,970,454
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$17,335,818
Research focus
Lung DiseasesLungTuberculosisImpairmentTuberculosis TreatmentSitePreventIndiaAdultLung InjuryPulmonary TuberculosisPulmonary FunctionRespiratory HealthChronicSurvivorsParticipantFundingMorbidity - Disease RateEnrollmentChronic Lung DiseaseNatural HistoryHealth Related Quality Of LifeDrug-SensitiveFunctional Status
Grant awards (13)
Interleukin-6 signaling, lung injury, and post-TB lung disease in TB-HIV$518,890
R01 · FY2025 · AI · contact PI
TB PuRe : Pulmonary rehabilitation to reduce post-tuberculosis morbidity$430,078
R01 · FY2025 · AI
TB PuRe : Pulmonary rehabilitation to reduce post-tuberculosis morbidity$94,312
R01 · FY2025 · AI
Interleukin-6 signaling, lung injury, and post-TB lung disease in TB-HIV$86,249
R01 · FY2025 · AI · contact PI
Interleukin-6 signaling, lung injury, and post-TB lung disease in TB-HIV$81,414
R01 · FY2025 · AI · contact PI
TB PuRe : Pulmonary rehabilitation to reduce post-tuberculosis morbidity$47,029
R01 · FY2025 · AI
Interleukin-6 signaling, lung injury, and post-TB lung disease in TB-HIV$743,698
R01 · FY2024 · AI · contact PI
TB PuRe : Pulmonary rehabilitation to reduce post-tuberculosis morbidity$587,913
R01 · FY2024 · AI
Phenotype, Progression and Immune Correlates of Post-Tuberculosis Lung Disease$239,666
R00 · FY2024 · AI · contact PI
TB PuRe : Pulmonary rehabilitation to reduce post-tuberculosis morbidity$682,368
R01 · FY2023 · AI
Phenotype, Progression and Immune Correlates of Post-Tuberculosis Lung Disease$249,000
R00 · FY2023 · AI · contact PI
Phenotype, Progression and Immune Correlates of Post-Tuberculosis Lung Disease$135,432
K99 · FY2021 · AI · contact PI
Phenotype, Progression and Immune Correlates of Post-Tuberculosis Lung Disease$135,300
K99 · FY2020 · AI · contact PI